A detailed history of Carlyle Group Inc. transactions in Quidel Ortho Corp stock. As of the latest transaction made, Carlyle Group Inc. holds 8,260,183 shares of QDEL stock, worth $332 Million. This represents 56.7% of its overall portfolio holdings.

Number of Shares
8,260,183
Previous 11,520,751 28.3%
Holding current value
$332 Million
Previous $383 Million 1.6%
% of portfolio
56.7%
Previous 45.71%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$29.96 - $46.4 $97.7 Million - $151 Million
-3,260,568 Reduced 28.3%
8,260,183 $377 Million
Q2 2024

Aug 09, 2024

SELL
$32.9 - $47.0 $30.9 Million - $44.2 Million
-939,432 Reduced 7.54%
11,520,751 $383 Million
Q2 2022

Aug 12, 2022

BUY
$89.06 - $117.64 $1.11 Billion - $1.47 Billion
12,460,183 New
12,460,183 $1.21 Billion

Others Institutions Holding QDEL

About QuidelOrtho Corp


  • Ticker QDEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 66,952,900
  • Market Cap $2.69B
  • Description
  • QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...
More about QDEL
Track This Portfolio

Track Carlyle Group Inc. Portfolio

Follow Carlyle Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carlyle Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Carlyle Group Inc. with notifications on news.